Oakmont Investment Advisors Inc. Takes Position in Stryker Corporation $SYK

Key Points

• Oakmont Investment Advisors initiated a position in Stryker by purchasing 6,709 shares valued at approximately $2.1 million, making SYK its 17th-largest holding. Institutional investors collectively own 77.09% of the company.
• Stryker reported quarterly EPS of $3.69, exceeding estimates of $3.49, while revenue rose 9.4% year over year to $6.59 billion. Analysts maintain a consensus “Moderate Buy” rating with an average price target of $386.28.
• The company declared a quarterly dividend of $0.88 per share, representing a $3.52 annualized payout and a 1.2% yield. Insiders sold roughly 351,267 shares worth $118.2 million over the past 90 days.

Oakmont Investment Advisors Inc. bought a new position in shares of Stryker Corporation (NYSE:SYK - Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 6,709 shares of the medical technology company's stock, valued at approximately $2,112,000. Stryker comprises approximately 1.5% of Oakmont Investment Advisors Inc.'s holdings, making the stock its 17th largest position.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in SYK. Gables Capital Management Inc. bought a new position in shares of Stryker in the 2nd quarter valued at about $25,000. Kilter Group LLC bought a new stake in shares of Stryker in the 2nd quarter valued at about $25,000. Godfrey Financial Associates Inc. acquired a new stake in Stryker in the 4th quarter valued at about $26,000. Sankala Group LLC acquired a new stake in Stryker in the 4th quarter valued at about $26,000. Finally, Compass Financial Management LLC bought a new position in Stryker during the second quarter worth about $27,000. 77.09% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Wolfe Research lowered Stryker from an "outperform" rating to a "peer perform" rating in a research note on Thursday, August 13th. Weiss Ratings reiterated a "hold (c)" rating on shares of Stryker in a research note on Friday, July 31st. Truist Financial boosted their target price on Stryker from $330.00 to $340.00 and gave the stock a "hold" rating in a report on Friday, July 31st. Royal Bank Of Canada dropped their price target on Stryker from $435.00 to $420.00 and set an "outperform" rating on the stock in a research note on Friday, July 31st. Finally, Citigroup reaffirmed a "buy" rating on shares of Stryker in a report on Thursday, August 13th. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $386.28.

Stryker Price Performance

Stryker stock opened at $302.92 on Friday. The company has a market capitalization of $116.19 billion, a price-to-earnings ratio of 31.39, a PEG ratio of 1.93 and a beta of 0.76. The stock's 50 day moving average is $328.84 and its 200-day moving average is $329.73. The company has a current ratio of 2.16, a quick ratio of 1.33 and a debt-to-equity ratio of 0.59. Stryker Corporation has a 12 month low of $281.00 and a 12 month high of $396.37.

Stryker (NYSE:SYK - Get Free Report) last announced its earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The company had revenue of $6.59 billion during the quarter, compared to analysts' expectations of $6.58 billion. During the same quarter in the previous year, the business posted $3.13 earnings per share. Stryker's quarterly revenue was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Equities research analysts expect that Stryker Corporation will post 15.03 EPS for the current year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a yield of 1.2%. The ex-dividend date is Wednesday, September 30th. Stryker's payout ratio is currently 36.48%.

Insider Buying and Selling

In other news, insider Dylan Crotty sold 441 shares of the stock in a transaction on Friday, August 21st. The stock was sold at an average price of $328.61, for a total value of $144,917.01. Following the completion of the transaction, the insider directly owned 6,102 shares in the company, valued at approximately $2,005,178.22. This represents a 6.74% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Ronda E. Stryker sold 50,000 shares of the firm's stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $340.10, for a total transaction of $17,005,000.00. Following the completion of the transaction, the director owned 2,251,375 shares of the company's stock, valued at approximately $765,692,637.50. This trade represents a 2.17% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 351,267 shares of company stock worth $118,197,701 in the last ninety days. 4.60% of the stock is owned by insiders.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source